R. Duarte (Vila Nova De Gaia, Portugal), G. Bothamley (London, United Kingdom)
Impact of African immigration on drug resistance to mycobacterium tuberculosis in Portugal C. Gaspar, C. Gomes, N. Diogo (Lisbon, Portugal)
| |
Double impact: Difficulties in treating patients with liver diseases from tuberculosis H. Makhlouf, N. Makhlouf, M. Metwally, H. A. Rashed (Assiut, Egypt)
| |
Hepatitis C virus infection among tuberculosis patients in Sohag Governorate: Seroprevalence and associated risk factors M. Badawy, M. Taha, L. Mohamed, A. Fathy (Sohag, Egypt)
| |
Detection of active TB among people living with HIV/AIDS and vulnerable population groups (commercial sex workers and injecting drug users) A. Solovyova, A. Golubkov, E. Borzunova, A. Chernov (Tomsk, Russian Federation; Boston, United States Of America)
| |
Tuberculosis screening among intravenous drug users (IDU) in Georgia M. Gegia, N. Kiria, I. Kalandadze (Tbilisi, Georgia)
| |
Managing tuberculosis in chronic kidney disease: An evaluation of patient treatment regimens A. Riding, P. Palchaudhuri, P. Begum, M. Ostermann, H. Milburn (London, United Kingdom)
| |
Prednisolone treatment does affect the performance of the QuantiFERON in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis E. Belard, S. Semb, M. Ruhwald, A. M. Werlinrud, B. Søborg, F. K. Jensen, H. Thomsen, A. Brylov, M. L. Hetland, I. Nordgaard-Lasen, I. Nordgaard-Lasen, P. Ravn (Hvidovre, Herlev, Amager, Denmark)
| |